There’s good news, ladies: A new type of birth control pill has been approved by the FDA! Quartette has a combination of levonorgestrel/ethinyl estradiol and ethinyl estradiol and can help prevent breakthrough bleeding.
According to Dr. James A. Simon, clinical professor of obstetrics and gynecology at the George Washington University School of Medicine:
“Breakthrough bleeding can be experienced with any birth control pill, especially during the first few months, and is one of the reasons a large number of women discontinue extended regimens. The estrogen in Quartette increases at specific points and provides four short light periods a year. Breakthrough bleeding decreases over time, which might help encourage patient adherence.”
Approval for the new drug came after a clinical trial in which Quartette was found to be 97% effective at preventing pregnancy. It works differently than most 30-day birth control pills: Quartette features a 91-day oral regimen, in which the dose of estrogen increases at three set point points over the first 84 days, while the amount of progestin remains the same. This is then is followed by seven days of 10 micrograms of ethinyl estradiol.
I’m in favor of any and all options that give a woman greater choice to prevent pregnancy. Many woman have problems with hormonal birth control, so perhaps Quartette might be a good option for women that have tried other pill regimens that didn’t work for their body or lifestyle. Breakthrough bleeding is a really common complaint, so if Quartette can prevent that for some pill-users, it really sounds like a great development for women.